|
|
||||||||
Department of Radiology, University of Missouri-Columbia and Nuclear Medicine Service, Harry S. Truman Memorial Veterans Hospital, Columbia, Missouri
Correspondence: For reprints contact: Joseph C. Hung, PhD, Diagnostic Nuclear Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
ABSTRACT
Technetium-99m-d,1-hexamethylpropyleneamine oxime[99Tc]d,1-HM-PAO) is a neutral-lipophilic chelate formed from a kit in high yield by stannous reduction of Na99TcO4. Of three methods used to analyze the purity of the 99mTc complexes, a single strip method using either as the developing solvent was the most rapid and simple to perform. The lipophilic chelate converts to 99mTcO4 and other hydrophilic products with time and this limits the useful lifetime of the preparations. The rate of decomposition of [99mTc]d,1-HM-PAO increased in the presence of excess stannous ion and at pH >9.
This article has been cited by other articles:
![]() |
A. Bao, B. Goins, R. Klipper, G. Negrete, and W. T. Phillips 186Re-Liposome Labeling Using 186Re-SNS/S Complexes: In Vitro Stability, Imaging, and Biodistribution in Rats J. Nucl. Med., December 1, 2003; 44(12): 1992 - 1999. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |